AOP Logo 320 (inc. strapline) GRAY (text)

STATEMENT re. Our Annual Meeting & COVID-19

The decision has been taken to postpone the 2020 Annual Meeting due to the evolving issues around COVID-19.
Instead, we will hold the Meeting Programme on 15 & 16 March 2021 (NOT 16 & 17  March – as first advertised), at the same venue in Oxford. We will shortly be contacting all members, abstract presenters and registered delegates.
We apologise for any inconvenience this decision causes and we look forward to seeing you in 2021 in Oxford.

Plenary lectures given by some of the most influential international medical practitioners and academic. The Annual Meeting is a unique chance to be at the cutting edge of interdisciplinary, translational medicine.

  • Infectious diseases – into the Future ~ in partnership with the Lancet Infectious Diseases
  • Diagnosis by DNA ~ in partnership with the Biochemical Society
  • Big Data in Clinical Research ~ in partnership with Health Data Research UK
  • New Targets in Cellular Metabolism ~ in partnership with Nature Medicine
  • Open Theme

Membership is open to all: clinicians; early career researchers; discovery scientists; industry affiliates. The AoP also has a community of elected fellows.

Register for our annual early career researchers workshop inviting conversation and debate with practitioners and clinicians at the forefront of scientific research today.

  • Join a unique professional community at the heart of interdisciplinary debate
  • Discounted rates for the annual meeting
  • Support for early career researchers and newly appointed consultants
  • Application for peer review fellowship status

Our grant structure includes support for early career members.

Find out more about our grants supporting a range of research activities, as well as our:

QJM, is a long-established, leading general medical journal. It focuses on internal medicine and publishes peer-reviewed articles which promote medical science and practice.

Published monthly, QJM includes original papers, editorials, reviews, commentary papers to air controversial issues, and a correspondence column.


Loading RSS Feed